Anastasia Bougea | Biological Networks | Innovative Research Award

Published on by Network Science

Innovative Research Award

Anastasia Bougea
National and Kapodistrian University of Athens

Anastasia Bougea
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 55629725400
Documents 136
Citations 2352
h-index 27
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0003-3006-8711

Anastasia Bougea is a Greek researcher affiliated with the National and Kapodistrian University of Athens whose scholarly work spans neurology, neurodegenerative diseases, clinical neuroscience, digital health, and data-driven approaches to understanding complex biological systems. Her publication record demonstrates sustained contributions to Parkinson’s disease, dementia-related disorders, neuropsychological assessment, and emerging machine-learning methodologies in healthcare research.[1] Through interdisciplinary investigations integrating clinical evidence, neurological biomarkers, and computational analysis, her research aligns with contemporary developments in biological network science and translational medicine.[2]

Abstract

This article summarizes the academic profile of Anastasia Bougea and evaluates her suitability for recognition through the Innovative Research Award. Her body of work reflects a multidisciplinary approach linking neurological disorders, clinical diagnostics, machine learning, mobile health technologies, and molecular mechanisms of neurodegeneration. The scope and continuity of her contributions indicate an active engagement with contemporary biomedical challenges and network-oriented approaches to disease understanding.[3]

Keywords

Biological Networks, Neurodegenerative Diseases, Parkinson’s Disease, Machine Learning, Clinical Neuroscience, Mobile Health, Dementia, Alpha-Synuclein, Biomarkers, Graph Analytics.

Introduction

Research into neurodegenerative diseases increasingly relies on interconnected biological data, computational modeling, and predictive analytics. Anastasia Bougea’s scholarly activities contribute to this evolving landscape through studies addressing disease mechanisms, clinical assessment tools, and technology-assisted healthcare solutions. Her work demonstrates the integration of biomedical knowledge with analytical methods relevant to modern network science applications.[4]

Research Profile

With 136 indexed publications, 2,352 citations, and an h-index of 27, Bougea has established a substantial academic presence. Her research portfolio encompasses Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia, non-coding RNA therapeutics, and digital health technologies. Her publication activity reflects sustained engagement with peer-reviewed international journals and collaborative research initiatives.[1]

Research Contributions

  • Applied machine learning techniques for predicting multiple system atrophy and progressive supranuclear palsy.
  • Investigated therapeutic opportunities involving non-coding RNAs in neurodegenerative diseases.
  • Reviewed molecular pathways associated with alpha-synuclein and GBA1-related neurological disorders.
  • Explored mobile health technologies supporting Parkinson’s disease management.

Publications

  • Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores (2026).
  • Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases (2026).
  • Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review (2026).
  • Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies (2025).
  • Mobile Health Technologies for the Management of Parkinson’s Disease (2025).

Research Impact

The impact of Bougea’s research is reflected through citation activity, interdisciplinary relevance, and practical implications for neurological healthcare. Her studies support improved understanding of disease progression, digital monitoring technologies, and predictive clinical tools. These contributions help bridge translational research with patient-centered applications and data-driven decision-making frameworks.[5]

Award Suitability

Anastasia Bougea demonstrates characteristics commonly associated with innovative research recognition, including interdisciplinary scholarship, measurable scientific impact, and continued publication productivity. Her integration of machine learning, molecular neuroscience, and mobile health technologies contributes to emerging approaches within biological networks and graph-informed biomedical analysis. These achievements provide a strong basis for consideration within the International Research Awards on Network Science & Graph Analytics.[6]

Conclusion

Bougea’s academic record reflects sustained contributions to neuroscience and neurodegenerative disease research. Her work combines clinical relevance with analytical innovation, supporting advancements in predictive medicine and network-based biomedical understanding. The breadth of her scholarly output and demonstrated impact support recognition within an international research award framework.

References

  1. Elsevier. (n.d.). Scopus author details: Anastasia Bougea, Author ID 55629725400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55629725400
  2. Bougea, A. (2026). Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores.
    DOI: https://doi.org/10.1016/j.bnd.2026.02.002
  3. Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases.
    DOI: https://doi.org/10.3390/ijms27073260
  4. Bougea, A. (2026). Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review.
    DOI: https://doi.org/10.3390/cells15050470
  5. Bougea, A. (2025). Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies.
    DOI: https://doi.org/10.3390/genes16121496
  6. Bougea, A. (2025). Mobile Health Technologies for the Management of Parkinson’s Disease.
    DOI: https://doi.org/10.1080/14737175.2025.2580468

Vipin Yadav | Biological Networks | Best Paper Award

Published on by Network Science

Best Paper Award

Vipin Yadav
Moffitt Cancer Center, United States

Vipin Yadav
Affiliation Moffitt Cancer Center
Country United States
Scopus ID 57210883410
Documents 11
Citations 54
h-index 5
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0001-9862-5233

Vipin Yadav is a researcher affiliated with Moffitt Cancer Center whose scholarly work spans cancer biology, immunotherapy, molecular oncology, and biological network analysis. His publications demonstrate a focus on understanding complex cellular interactions, signaling mechanisms, and therapeutic interventions relevant to melanoma and related malignancies. Through contributions involving translational research and emerging biomedical technologies, Yadav has participated in advancing scientific understanding of biological systems and network-driven disease mechanisms. His publication record and citation impact reflect active engagement in contemporary biomedical research and support consideration for recognition within the field of Biological Networks.[1]

Abstract

This article evaluates the academic profile of Vipin Yadav in relation to the Best Paper Award category. His research activities emphasize cancer immunology, molecular mechanisms of melanoma progression, therapeutic response pathways, and innovative biomedical interventions. Recent publications demonstrate engagement with clinically relevant topics including mRNA-lipid nanoparticle CAR-T technologies, immunogenic cell death, and molecular determinants of treatment sensitivity. These contributions reflect interdisciplinary research linking biological networks with translational medicine and cancer therapeutics.[2]

Keywords

Biological Networks, Cancer Research, Melanoma, Immunotherapy, CAR-T Cells, Translational Medicine, Molecular Oncology, Network Science.

Introduction

Modern biomedical research increasingly relies on network-based approaches to understand disease progression and therapeutic response. Researchers investigating cellular signaling, immune interactions, and genomic regulation contribute significantly to biological network science. Within this context, Vipin Yadav’s work addresses molecular and cellular processes associated with cancer biology, offering insights that support both scientific understanding and clinical translation.[3]

Research Profile

According to available scholarly metrics, Yadav has authored multiple peer-reviewed publications, accumulating citations across oncology and biomedical science disciplines. His research portfolio demonstrates participation in studies involving melanoma biology, immune modulation, cell death mechanisms, and emerging therapeutic platforms. The combination of publication activity, citation performance, and interdisciplinary collaboration indicates an active contribution to contemporary cancer research.[1]

Research Contributions

  • Investigation of immunogenic cell death pathways in NRAS-mutant melanoma.
  • Research on nitrosylation mechanisms affecting therapeutic responses.
  • Contributions to mRNA-lipid nanoparticle CAR-T cell engineering and clinical translation.
  • Studies examining DNA damage mechanisms and delayed CPD formation.
  • Integration of molecular biology and biological network perspectives in cancer research.

Publications

  • In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical Translation (2026).
  • Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway (2025).
  • Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors (2025).

Research Impact

The impact of Yadav’s research is reflected through citation activity, publication in established journals, and relevance to translational oncology. His investigations address clinically significant questions concerning immune responses, targeted therapies, and cancer treatment resistance. Such research contributes to the broader scientific effort to improve therapeutic outcomes and expand understanding of complex biological interaction networks.[4]

Award Suitability

Vipin Yadav demonstrates characteristics commonly associated with Best Paper Award consideration, including publication in recognized scientific journals, engagement with innovative biomedical technologies, and contributions to biologically relevant network research. His recent scholarly outputs address significant challenges in oncology and immunotherapy while maintaining relevance to network-driven analyses of disease processes. The quality and topical importance of these contributions support recognition within the International Research Awards on Network Science & Graph Analytics framework.[5]

Conclusion

Vipin Yadav’s academic record reflects sustained involvement in cancer biology, molecular research, and translational medicine. Through publications addressing melanoma, immunotherapy, and emerging therapeutic technologies, he contributes to the advancement of biological network understanding. Based on available scholarly indicators and research outputs, his profile aligns with the objectives of recognizing impactful scientific research through the Best Paper Award category.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Vipin Yadav, Author ID 57210883410. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57210883410
  2. Biomedicines. (2026). In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical Translation.
    https://doi.org/10.3390/biomedicines14061276
  3. Journal of Investigative Dermatology. (2025). Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway.
    https://doi.org/10.1016/j.jid.2025.09.011
  4. Cancer Research. (2025). Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.
    https://doi.org/10.1158/0008-5472.CAN-24-0693
  5. ORCID. (n.d.). Researcher Profile: Vipin Yadav.
    https://orcid.org/0000-0001-9862-5233
  6. International Research Awards on Network Science & Graph Analytics. (n.d.). Award Program Information.
    networkscience-conferences.researchw.com

Liao Jinfeng | Biological Networks | Research Excellence Award

Published on by Network Science

Prof. Liao Jinfeng | Biological Networks | Research Excellence Award

Sichuan University | China

Liao Jinfeng, a Young Yangtze River Researcher and Doctoral Supervisor, currently serves as a Researcher at the West China School of Stomatology, Sichuan University. He completed his undergraduate studies at the West China School of Pharmacy, Sichuan University (2006–2010), followed by a direct PhD at the State Key Laboratory of Biotherapy, Sichuan University (2010–2015) under the supervision of Professor Qian Zhiyong. He began his academic career as a Lecturer at the West China School of Stomatology (2015–2017), completed postdoctoral research under Professor Li Bei through the Hong Kong Polytechnic University “Hong Kong Scholars” Program (2017–2019), and subsequently served as an Associate Professor at the same institution (2017–2021). His major scientific contributions lie in the development of materials for maxillofacial bone tissue repair, leading 7 research projects including 3 funded by the National Natural Science Foundation of China. Dr. Liao has published 52 SCI papers as corresponding or first author in top-tier journals such as Bone Res, Nano Lett, Bioact Mater, Int J Oral Sci, and J Nanobiotech, with 12 publications having an impact factor above 10, 2 cover articles, 6 highly cited papers, and 3 hot papers. His work has been cited 3605 times in prestigious journals including Chem. Rev., Chem. Soc. Rev., Adv. Drug Delivery System, and Adv. Mater., with 5 papers surpassing 100 citations and an outstanding H-index of 36. He has applied for 5 Chinese invention patents and was selected as a “Hong Kong Scholar” by the Ministry of Human Resources and Social Security in 2016.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Bilayer hydrogel microneedles with mild photothermal effect promote infectious skin regeneration", Journal of Materials Chemistry, Gu, W.; Ye, X.; Xie, X.; Tan, B.; Qi, T.; Liao, J, 2025

"Development of a novel hyaluronic acid/alginate/RANKL degradable microneedle patch for accelerating bone remodeling and orthodontic tooth movement through promoting osteoclastogenesis", Shan, Y.; Jin, Y.; Zhang, X.; Tang, Y.; Lai, W.; Liao, J.; Wu, M.; Long, H.,  Journal article, 2025.

"Injectable Hydrogel as Intracanal Medication for Root Canal Disinfection", Cao, M.; Wu, D.; Tu, H.; Mou, B.; Kang, J.; Liao, J.; Yang, J, Journal of Dental Research, 2025.

"Photothermal sensitive nanocomposite hydrogel for infectious bone defects", Wu, Y.; Xie, X.; Luo, G.; Xie, J.; Ye, X.; Gu, W.; Mo, A.; Qian, Z.; Zhou, C.; Liao, J, Bone Research, 2025.

"Self-degradable nanoparticles hybrid hydrogel with cascade thermal control and spontaneous ion release for complex bone defect regeneration", Yang, S.; Zheng, Z.; Zhang, M.; Tan, B.; Zhang, X.; Chen, W.; Liao, J, Chemical Engineering Journal, 2025.

Dejen Getaneh Feleke | Biological Networks | Editorial Board Member

Published on by Network Science

Dr. Dejen Getaneh Feleke | Biological Networks | Editorial Board Member

Debre Tabor University | Ethiopia

Dr. Dejen Getaneh Feleke is an enthusiastic Ethiopian lecturer, clinician, and researcher dedicated to optimizing child health, with a strong academic portfolio that includes 38 publications-35 primary articles and 3 systematic reviews and meta-analyses-of which six are principal-authored and 21 are published in first-quartile (Q1) journals. He serves on the Editorial Board of PLOS ONE and contributes as a reviewer for several international journals, including PLOS ONE, AIDS and Behavior, Journal of Pediatrics and Infants, Academy of Educational Leadership Journal, International Journal of Africa Nursing Sciences, and Journal of Nutritional Science, having reviewed more than 18 manuscripts. Beyond academia, he has led impactful community service initiatives supporting Ethiopian child and neonatal health. Since 2016, he has provided dedicated clinical care to sick neonates and children in the Neonatal Intensive Care Unit and pediatric wards at Debre Tabor Comprehensive Specialized Hospital, contributing significantly to improving pediatric health outcomes in Ethiopia.

Profiles: Orcid

Featured Publications

"Magnitude and predictors of mild cognitive impairment among older populations in Africa: a systematic review and meta-analysis", Sintayehu Asnakew; Jessica Nealon; Ayele Semachew Kasa; Gashaw Walle Ayehu; Dejen Getaneh Feleke; Tigabu Munye Aytenew; Victoria Traynor, Translational Psychiatry, 2025.

"Prevalence and determinants of mental distress among patients admitted in medical and surgical wards of public hospitals in South Gondar zone, Ethiopia", Abraham Tsedalu Amare; Tekalign Amera Birlie; Dejen Getaneh Feleke; Tigabu Munye Aytenew; Yeshiambaw Eshetie; Berihun Bantie; Molla Azmeraw; Gashaw Walle Ayehu; Tamiru Alene; Yosef Gebremikael Dubale et al., Scientific Reports, 2025.

"Knowledge levels of health professional working in Ethiopia toward disaster preparedness, systematic review and meta-analysis", Sheganew Fetene Tassew; Temesgen Ayenew; Tadila Dires Nega; Berihun Bantie; Dejen Getaneh Feleke, International Journal of Africa Nursing Sciences, 2024.

"Practice of non-pharmacological post-operative pain management and associated factors among nurses working in public referral hospitals of Amhara regional state, Ethiopia, 2019", Dejen Getaneh Feleke; Ermias Sisay Chanie; Sheganew Fetene Tassaw; Tadila Dires, International Journal of Africa Nursing Sciences, 2024.

"Viral load undetectable state and predictors among children and adolescents living with HIV in South Gondar, Ethiopia, 2023: an 8-year retrospective cohort study, Ermias Sisay Chanie; Dejen Getaneh Feleke; Tigabu Desie Emiru; Abere Gebru Abuhay; Habtamu Shimels Hailemeskel; Astewle Andargie Baye; Berihun Bantie; Abraham Tsedalu Amare; Tadila Dires Nega; Denekew Tenaw Anley et al., BMJ Open, 2024.

Sarah F. Leibowitz | Biological Networks | Most Cited Article Award

Published on by Network Science

Dr. Sarah F. Leibowitz | Biological Networks | Most Cited Article Award

The Rockefeller University | United States

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Sarah F. Leibowitz began her scholarly journey with a strong foundation in behavioral neurobiology, setting the stage for a career centered on understanding complex brain-behavior relationships. Her educational path led her to specialize in the neurochemical regulation of behavior, which ultimately culminated in a Ph.D. and her current role at The Rockefeller University. Her early academic interests were shaped by the intersections of neuroscience, psychology, and biology, guiding her toward a focus on substance use and its developmental implications.

PROFESSIONAL ENDEAVORS

Currently serving as a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology, Dr. Leibowitz has established herself as a leading researcher in the neurobiology of addiction. Her work bridges multiple substances of abuse—alcohol, nicotine, and highly palatable foods—by exploring shared neurochemical pathways and behavioral outcomes. Her expertise in rodent models enables her to dissect the neural circuits and neurotransmitter systems responsible for transitioning from casual substance use to dependency.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Leibowitz's research examines how brain reward systems and emotional traits like novelty-seeking, impulsivity, and anxiety influence substance use. Her studies uncover neurochemical parallels across different substances—fat, alcohol, and nicotine—highlighting the common mechanisms that underpin addiction. More recently, she has delved into the developmental impacts of maternal substance use, revealing how exposure during gestation can lead to long-lasting changes in offspring brain architecture and behavior. Her focus on brain reprogramming, early detection of addiction risk, and preventive strategies positions her work at the cutting edge of behavioral neurobiology.

IMPACT AND INFLUENCE

Dr. Leibowitz's investigations have significantly contributed to our understanding of how addiction develops and persists. Her insights into embryonic exposure effects have profound implications for public health, maternal care, and early intervention. Through translational models such as rodents and zebrafish, she has created pathways to study substance-induced neurodevelopmental disorders with broad biomedical relevance. Her collaborative efforts with scientists like Olga Karatayev and Adam Collier demonstrate her leadership in interdisciplinary research.

ACADEMIC CITES

Dr. Leibowitz’s scholarly work is highly regarded, as evidenced by her publications in top-tier journals like International Journal of Molecular Sciences, Addiction Biology, Journal of Neuroinflammation, Neuroscience, and Alcoholism: Clinical and Experimental Research. Among her recent influential works are:

  • “Melanin-Concentrating Hormone (MCH): Role in Mediating Reward-Motivated and Emotional Behavior” (2025)

  • “Neurological Disorders Induced by Drug Use” (2024)

  • “Embryonic Ethanol Exposure and Behavioral Disturbances” (2022)
    Her articles are widely cited, reflecting her strong academic influence in behavioral neurobiology and substance abuse research.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Leibowitz is shaping a legacy as a pioneer in developmental addiction neuroscience. Her continued research into the chemokine and neuroimmune systems, especially in relation to maternal and embryonic exposure to addictive substances, is expected to inform future therapeutic and preventative approaches. As the societal burden of addiction and mental health grows, her work will likely influence policy, early childhood healthcare, and neuroscience-based interventions. Her ongoing projects aim to identify biomarkers of susceptibility and mechanisms for reversing early-life brain changes, ensuring that her contributions will remain vital in both academic and clinical spheres.

OTHER IMPORTANT TOPICS

  • Collaborative Approach: Dr. Leibowitz works closely with a dynamic team of co-authors, fostering innovation across institutions and disciplines.

  • Animal Models as Research Tools: Her pioneering use of zebrafish and rodent models expands the toolkit for studying addiction and neurodevelopment.

  • Focus on Sex Differences: Several of her studies highlight sexually dimorphic responses in brain development and substance effects, addressing a critical gap in addiction science.

NOTABLE PUBLICATIONS

"Melanin-Concentrating Hormone (MCH): Role in Mediating Reward-Motivated and Emotional Behavior and the Behavioral Disturbances Produced by Repeated Exposure to Reward Substances" 

  • Author: Olga Karatayev; Sarah F. Leibowitz
  • Journal: International Journal of Molecular Sciences
  • Year: 2025

"Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment" 

  • Author: Olga Karatayev; Adam D. Collier; Stella R. Targoff; Sarah F. Leibowitz
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis" 

  • Author: Adam D. Collier; Abdul R. Abdulai; Sarah F. Leibowitz
  • Journal: Cells
  • Year: 2023

"Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections" 

  • Author: Nushrat Yasmin; Adam D. Collier; Abdul R. Abdulai; Olga Karatayev; Boyi Yu; Milisia Fam; Sarah F. Leibowitz
  • Journal: Cells
  • Year: 2025

"Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances" 

  • Author: Adam D. Collier; Nushrat Yasmin; Guo‐Qing Chang; Olga Karatayev; Nailya Khalizova; Milisia Fam; Abdul R. Abdulai; Boyi Yu; Sarah F. Leibowitz
  • Journal: Addiction Biology
  • Year: 2025

George Goulielmos | Biological Networks | Best Academic Researcher Award

Published on by Network Science

Dr. George Goulielmos | Biological Networks | Best Academic Researcher Award

Medical School, University of Crete | Greece

Author Profile

Scopus

Google Scholar

DR. GEORGE GOULIELMOS’S BIOGRAPHY

EARLY ACADEMIC PURSUITS

Dr. George Goulielmos began his academic journey with a Bachelor of Science in Biology from the University of Patras, Greece, between September 1980 and March 1985. His profound interest in the life sciences led him to pursue a Doctor of Philosophy (Ph.D.) in Biology at the same institution, which he completed in December 1989. During his formative years as a scholar, he demonstrated a strong inclination toward evolutionary biology, notably contributing to a project on the experimental approach of speciation theory, supported by the Greek General Secretariat of Research and Technology. This foundational experience laid the groundwork for his later research pursuits in molecular biology, genetics, and immunology.

PROFESSIONAL ENDEAVORS

Dr. Goulielmos has held a multitude of prestigious academic and research positions across Europe. His career began with research appointments at the Institute of Marine Biology of Crete and the Institute of Molecular Biology and Biotechnology (IMBB). Between 1993 and 1997, he served as a postdoctoral researcher at the European Molecular Biology Laboratory (EMBL) in Germany and as a visiting scientist at the BIOZENTRUM, University of Basel, Switzerland. He later contributed significantly to the Department of Biology, University of Crete, and held positions in Neurology and Sensory Organs. His academic appointments evolved from Lecturer to Professor in Human Molecular Genetics at the School of Medicine, University of Crete, where he has served since 1999. Since April 2016, he has also led the Molecular Pathology and Human Genetics Section within the Internal Medicine Laboratory.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Goulielmos's research focuses primarily on Human Molecular Genetics, with a specialized interest in autoimmune diseases, genetic epidemiology, and personalized medicine. He has made pivotal contributions to the study of Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), endometriosis, and other complex diseases. His work incorporates genetic analysis, molecular diagnostics, and population genetics, integrating interdisciplinary tools to understand disease susceptibility and progression. He has collaborated with world-renowned scientists and institutions, applying cutting-edge technologies to dissect the genetic basis of autoimmunity and inflammation. He also participated in the European "External Quality Assessment" initiative, reinforcing the clinical reliability of molecular diagnostics.

IMPACT AND INFLUENCE

Dr. Goulielmos has gained widespread recognition for his scholarly influence in molecular genetics and immunology. As a reviewer for over 100 international peer-reviewed journals, including Nature Communications, Scientific Reports, Human Molecular Genetics, and Rheumatology, he has played a crucial role in shaping the quality and direction of contemporary research. His editorial contributions to over 20 scientific journals and guest editorship for Clinical and Developmental Immunology further emphasize his standing in the academic community. Through his peer evaluations, mentorship, and collaborations, Dr. Goulielmos has significantly influenced both young researchers and the wider scientific discourse.

ACADEMIC CITES AND RECOGNITION

Dr. Goulielmos's academic works have been extensively cited in high-impact publications, particularly in the fields of autoimmune disease research and genetic epidemiology. His work is indexed in databases such as PubMed, Scopus, and Web of Science, highlighting the global relevance of his findings. He is a respected reviewer for leading scientific institutes and funding bodies, including the Dutch Arthritis Association, the Wellcome Trust (UK), and the European University of Cyprus. His projects have received both national and European grants, under frameworks like FP5, FP6, FP7, and HEALTH (ALCOVE - Alzheimer Joint Action).

LEGACY AND FUTURE CONTRIBUTIONS

As a professor, researcher, editor, and collaborator, Dr. Goulielmos continues to build a legacy defined by academic excellence, scientific rigor, and collaborative innovation. His leadership of the Molecular Pathology and Human Genetics Section and mentorship of early-career scientists solidify his commitment to nurturing the next generation of researchers. Looking forward, his work is poised to make further contributions to personalized medicine, particularly in tailoring treatments for complex autoimmune diseases through molecular and genetic profiling. His sustained involvement in international projects and his deep commitment to translational research ensure that his contributions will continue to influence both academic circles and clinical practice globally.

OTHER SIGNIFICANT HIGHLIGHTS

INTERNATIONAL COLLABORATIONS: Dr. Goulielmos has partnered with globally renowned researchers such as Prof. Timothy Niewold (NYU), Profs. Anne Barton and Jane Worthington (Manchester), and Prof. Andreas Radbruch (Berlin), enhancing research on autoimmune disorders.

EDITORIAL BOARD MEMBERSHIPS: He has held key editorial roles in journals such as Frontiers in Immunology, International Journal of Molecular Sciences, and Journal of Arthritis, advocating scientific quality and editorial integrity.

FUNDING AND GRANTS: He has successfully led research funded by Greek national programs (Thalis, Aristeia, Irakleitos) and EU Framework Programs (FP5, FP6, FP7), showcasing his ability to attract competitive funding and drive high-impact research.

NOTABLE PUBLICATIONS

"Comment on: Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel" 

  • Author: MI Zervou, GN Goulielmos
  • Journal: Rheumatology
  • Year: 2025

"Risk of Venous Thrombotic Events in Systemic Lupus Erythematosus Patients: Genetic Insights" 

  • Author: MI Zervou, GN Goulielmos
  • Journal: Journal of Cellular Immunology
  • Year: 2025

"Endometriosis and Sjögren's syndrome: Genetics insights on the observed bidirectional association of these diseases" 

  • Author: MI Zervou, GN Goulielmos
  • Journal: Acta Obstetricia et Gynecologica Scandinavica
  • Year: 2025

"Comment on" beyond physical pain: A large-scale cohort study on endometriosis trends and mental health correlates"" 

  • Author: MI Zervou, GN Goulielmos
  • Journal: Journal of psychosomatic research
  • Year: 2024

"AB0002 The genetic background of ankylosing spondylitis indicates a strong correlation with other autoimmune diseases" 

  • Author: L Papageorgiou, M Zervou, T Zormpa, R Golfinopoulou, D Vlachakis
  • Journal: Annals of the Rheumatic Diseases
  • Year: 2024